Evidence map›Paper›PMID 30718280›Full record

ArticleThe Journal of biological chemistry2019

The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.

Johanna Bialas, Annika N Boehm, Nicola Catone, Annette Aichem, Marcus Groettrup

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Johanna BialasFrom the Division of Immunology, Department of Biology, University of Konstanz, 78464 Konstanz, Germany and.
Annika N BoehmFrom the Division of Immunology, Department of Biology, University of Konstanz, 78464 Konstanz, Germany and.
Nicola Catonethe Biotechnology Institute Thurgau at the University of Konstanz, 8280 Kreuzlingen, Switzerland.
Annette AichemFrom the Division of Immunology, Department of Biology, University of Konstanz, 78464 Konstanz, Germany and Annette.Aichem@bitg.ch.
Marcus GroettrupFrom the Division of Immunology, Department of Biology, University of Konstanz, 78464 Konstanz, Germany and.ORCID 0000-0002-5423-6399
University of Konstanz · DEBiotechnology Institute Thurgau · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The deubiquitylation of target proteins is mediated by deubiquitylating enzymes (DUB) such as OTUB1, which plays an important role in immune response, cell cycle progression, and DNA repair. Within these processes, OTUB1 reduces the ubiquitylation of target proteins in two distinct ways, either by using its catalytic DUB activity or in a noncatalytic manner by inhibiting the E2-conjugating enzyme. Here, we show that the ubiquitin-like modifier FAT10 regulates OTUB1 stability and functionality in different ways. Covalent FAT10ylation of OTUB1 resulted in its proteasomal degradation, whereas a noncovalent interaction stabilized OTUB1. We provide evidence that OTUB1 interacts directly with FAT10 and the E2-conjugating enzyme USE1. This interaction strongly stimulated OTUB1 DUB activity toward Lys-48-linked diubiquitin. Furthermore, the noncovalent interaction between FAT10 and OTUB1 not only enhanced its isopeptidase activity toward Lys-48-linked ubiquitin moieties but also strengthened its noncatalytic activity in reducing Lys-63 polyubiquitylation of its target protein TRAF3 (TNF receptor-associated factor 3). Additionally, the cellular clearance of overall polyubiquitylation by OTUB1 was strongly stimulated through the presence of FAT10. The addition of FAT10 also led to an increased interaction between OTUB1 and its cognate E2 UbcH5B, implying a function of FAT10 in the inhibition of polyubiquitylation. Overall, these data indicate that FAT10 not only plays a role in covalent modification, leading its substrates to proteasomal degradation, but also regulates the stability and functionality of target proteins by interacting in a noncovalent manner. FAT10 is thereby able to exert a major influence on ubiquitylation processes.

Indexed as

Cysteine EndopeptidasesDeubiquitinating EnzymesHEK293 CellsHumansProteasome Endopeptidase ComplexProtein BindingProteolysisSNARE ProteinsUbiquitinUbiquitinationUbiquitinsVesicular Transport ProteinsCysteine EndopeptidasesDeubiquitinating EnzymesOTUB1 protein, humanProteasome Endopeptidase ComplexSNARE ProteinsUBD protein, humanUbiquitinUbiquitinsUse1 protein, humanVesicular Transport Proteinsenzyme activityFAT10inflammationproteasomeubiquitinubiquitin-conjugating enzyme (E2 enzyme)ubiquitin-like proteinubiquitin thioesterase (OTUB1)ubiquitylation (ubiquitination)USE1

Identifiers

PMID30718280
PMCPMC6433071
OpenAlexW2914487443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.